Spatio-temporal mapping of immune cell dynamics during human sequential lymph node metastasis
Qiuchen Zhao, Yongjin LuiD, Z. Shi, Hongrun Zhang, Cheuk Shuen Li, Rongrong ZhaoiD, Yuanchao LingiD, Yongsheng GaoiD, Zhaopeng ZhangiD, X. Sun, Yuping QianiD, Xiaowen WangiD, Chunjian Wang, Binbin Cong, Xiang Ni, Yanfang LiuiD, Miaoqing ZhaoiD, Yongsheng WangiD, Bidesh MahataiD, Pengfei QiuiD
Abstract
Regional lymph node (LN) metastasis critically influences distant metastatic progression, anti-tumour immunity, and patient prognosis. While tumour-induced immune modulation in tumour-draining LNs (TDLNs) has been extensively studied using murine models, the systematic reconstruction of the immune system from primary tumours through TDLNs and subsequent lymph nodes in human cancer progression remains understudied. Here, we utilised integrated multi-omics approaches, including imaging mass cytometry, single-cell RNA sequencing, Visium and Xenium spatial transcriptomics, and multi-colour immunofluorescence to systematically characterise immune cell dynamics across 147 paired primary tumours, sentinel TDLNs (S-TDLNs), and secondary axillary LNs (ALNs) obtained from 50 treatment-naive triple-negative breast cancer patients with different progression statuses. Our comprehensive profiling revealed critical immune alterations, such as decreased type-2 conventional dendritic cells (cDC2), naive T cells, and B cells, along with an increase in immunosuppressive macrophages. Developing a novel single-cell transformer model, we identified substantial alterations in various immune cell populations, notably MARCO+ macrophages, which strongly correlated with breast cancer patient survival outcomes. Spatial analysis combined with our newly integrated cell-cell interaction platform revealed diminished immune cell communication and impaired priming interactions among dendritic cells, B cells, and T cells within metastatic lymph nodes and primary tumour sites. In an independent neoadjuvant immunotherapy cohort of 36 TNBC patients with 52 lymph node samples, we found preservation of CD1c cDC2 in lymph nodes predicted pathological complete response and longer event-free survival, highlighting cDC2 as a potential biomarker and therapeutic target. Collectively, this systematic mapping of immune landscape alterations during human sequential LN metastasis provides essential insights for understanding cancer metastasis mechanisms and paves the way for innovative immunotherapeutic strategies.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Spatial Transcriptomics of TNBC tumours and corresponding lymph node metastasis reveals immune hubs driven by TNF/NF-κB signalling of TMSB4X and CD74 expressing cells.
Adrian Perdyan, Urszula Ławrynowicz, … Jakub Mieczkowski·bioRxiv·Mar 17, 2026
- Single-cell immune profiling of regional lymph nodes during early-stage breast cancer progression
Marit Otterlei Fjørtoft, Øystein Garred, … Inga Hansine Rye·bioRxiv·May 21, 2026
- Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors
L. Zhu, J. L. Narloch, … A. V. Lee·bioRxiv·Jan 20, 2019
- Breast Cancer Remodels Lymphatics in Sentinel Lymph Nodes
Dominik Eichin, Diana Lehotina, … Sirpa Jalkanen·Nature CommunicationsPeer-reviewed·Nov 17, 2025
- Breast cancer progression and metastasis to lymph nodes reveals cancer cell plasticity and MHC class II-mediated immune regulation
P.-J. Lei, E. Pereira, … T. P. Padera·bioRxiv·Oct 30, 2022
- Selective elimination of CD169+ macrophages in lymph nodes invaded by breast cancers
Y. Maeshima, T. R. Kataoka, … K. Kawaguchi·bioRxiv·Aug 2, 2023